StockData
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30
$0.49−0.00 (-0.26%)

Close on Nov 17, 2026Market cap $2.91MP/E –Yield –

IM Cannabis operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -C$11.59M. The highest annual figure on record is -C$8.25M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-C$11.59M–
FY2024Dec 31, 2024-C$10.23M–
FY2023Dec 31, 2023-C$12.79M–
FY2022Dec 31, 2022-C$30.79M–
FY2021Dec 31, 2021-C$23.04M–
FY2020Dec 31, 2020-C$8.25M–
FY2019Dec 31, 2019-C$10.28M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-C$2.09M–
Q2 FY2025Jun 30, 2025-C$350.00K–
Q2 FY2024Jun 30, 2024-C$2.87M–
Q2 FY2023Jun 30, 2023-C$1.75M–
Q2 FY2022Jun 30, 2022-C$5.62M–
Q2 FY2021Jun 30, 2021-C$10.72M–

More IM Cannabis figures

See a number that looks wrong?